ConductScience.org, home

Trial · NCT00542425

Participant flow30

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Extended 24 Weeks of TreatmentCOMPLETEDPlacebo10
Extended 24 Weeks of TreatmentCOMPLETEDBA058 20 µg11
Extended 24 Weeks of TreatmentCOMPLETEDBA058 40 µg8
Extended 24 Weeks of TreatmentCOMPLETEDBA058 80 µg6
Extended 24 Weeks of TreatmentCOMPLETEDTeriparatide13
Extended 24 Weeks of TreatmentNOT COMPLETEDPlacebo1
Extended 24 Weeks of TreatmentNOT COMPLETEDBA058 20 µg2
Extended 24 Weeks of TreatmentNOT COMPLETEDBA058 40 µg2
Extended 24 Weeks of TreatmentNOT COMPLETEDBA058 80 µg1
Extended 24 Weeks of TreatmentNOT COMPLETEDTeriparatide1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00542425/flow?page=2